Journal of Cell Science, Vol 114, Issue 10 1901-1912, Copyright © 2001 by Company of Biologists

JOURNAL ARTICLES

Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain

E Brault, A Gautreau, M Lamarine, I Callebaut, G Thomas and L Goutebroze
Laboratoire de Genetique des Tumeurs, U434 INSERM-CEPH Fondation Jean Dausset, 75010 Paris, France. thomas@cephb.fr

The neurofibromatosis type 2 (NF2) tumor suppressor protein, known as schwannomin or merlin, is involved in linking membrane proteins to the cytoskeleton. Like the related ERM proteins, schwannomin has long been suspected of exhibiting a complex 3D organization caused by the association of different regions within the protein. Intramolecular interactions characterized to date are linking N-terminal sequences of the protein to C-terminal sequences. Here, we demonstrate, by a biochemical approach, the existence of a structured domain entirely contained within the N-terminal half of schwannomin. This structure, which is resistant to chymotryptic digestion, encompasses the FERM domain (residues 19-314), but excludes the 18 extreme N-terminal residues specific to schwannomin. The structure is disrupted by some, but not all, naturally occurring NF2 mutations. We investigated the significance of this structured domain in schwannomin cellular functions and found that normal schwannomin localization beneath the plasma membrane is directly dependent on proper folding of the N-terminal domain. In addition, folding of the N-terminal domain influences schwannomin interaction with actin through two novel actin-binding sites located in this region. These results suggest that loss of activity of several naturally occurring schwannomin mutants is due to disruption of the fold of the N-terminal domain, leading to loss of both membrane localization and actin association.

This article has been cited by other articles:

				B. K. Cole, M. Curto, A. W. Chan, and A. I. McClatchey Localization to the Cortical Cytoskeleton Is Necessary for Nf2/Merlin-Dependent Epidermal Growth Factor Receptor Silencing Mol. Cell. Biol., February 15, 2008; 28(4): 1274 - 1284. [Abstract] [Full Text] [PDF]

				H. Lee, D. Kim, H. C. Dan, E. L. Wu, T. M. Gritsko, C. Cao, S. V. Nicosia, E. A. Golemis, W. Liu, D. Coppola, et al. Identification and Characterization of Putative Tumor Suppressor NGB, a GTP-Binding Protein That Interacts with the Neurofibromatosis 2 Protein Mol. Cell. Biol., March 15, 2007; 27(6): 2103 - 2119. [Abstract] [Full Text] [PDF]

				A. I. McClatchey and M. Giovannini Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin Genes & Dev., October 1, 2005; 19(19): 2265 - 2277. [Abstract] [Full Text] [PDF]

				N. Manchanda, A. Lyubimova, H.-Y. H. Ho, M. F. James, J. F. Gusella, N. Ramesh, S. B. Snapper, and V. Ramesh The NF2 Tumor Suppressor Merlin and the ERM Proteins Interact with N-WASP and Regulate Its Actin Polymerization Function J. Biol. Chem., April 1, 2005; 280(13): 12517 - 12522. [Abstract] [Full Text] [PDF]

				A. Gautreau, B. T. Fievet, E. Brault, C. Antony, A. Houdusse, D. Louvard, and M. Arpin Isolation and Characterization of an Aggresome Determinant in the NF2 Tumor Suppressor J. Biol. Chem., February 14, 2003; 278(8): 6235 - 6242. [Abstract] [Full Text] [PDF]

				C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178. [Abstract] [Full Text] [PDF]

				M. Kressel and B. Schmucker Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15 Hum. Mol. Genet., September 15, 2002; 11(19): 2269 - 2278. [Abstract] [Full Text] [PDF]

				A. Gautreau, J. Manent, B. Fievet, D. Louvard, M. Giovannini, and M. Arpin Mutant Products of the NF2 Tumor Suppressor Gene Are Degraded by the Ubiquitin-Proteasome Pathway J. Biol. Chem., August 23, 2002; 277(35): 31279 - 31282. [Abstract] [Full Text] [PDF]

				T. Shimizu, A. Seto, N. Maita, K. Hamada, S. Tsukita, S. Tsukita, and T. Hakoshima Structural Basis for Neurofibromatosis Type 2. CRYSTAL STRUCTURE OF THE MERLIN FERM DOMAIN J. Biol. Chem., March 15, 2002; 277(12): 10332 - 10336. [Abstract] [Full Text] [PDF]

				C.-X. Sun, V. A. Robb, and D. H. Gutmann Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation J. Cell Sci., January 11, 2002; 115(21): 3991 - 4000. [Abstract] [Full Text] [PDF]

				M. Jannatipour, P. Dion, S. Khan, H. Jindal, X. Fan, J. Laganiere, A. H. Chishti, and G. A. Rouleau Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains J. Biol. Chem., August 24, 2001; 276(35): 33093 - 33100. [Abstract] [Full Text] [PDF]